PDRN Supplements Market to Reach USD 1.58 Billion by 2035
The global Polydeoxyribonucleotide (PDRN) supplements market is undergoing a structural expansion, transitioning from specialized aesthetic injectables into mainstream therapeutic nutrition, oral supplements, and hybrid cosmeceutical routines, according to latest insights by Future Market Insights. Extracted primarily from marine DNA sources (such as salmon and trout sperm DNA), PDRN provides essential nucleotides that stimulate tissue repair, modulate inflammation, and accelerate cellular regeneration.
